Vitasora Health (VHL) Q1 2027 TU earnings summary

Executive summary

• September-quarter organic growth accelerated: operating revenue rose 29% QoQ to US$960,504, led by fee-for-service care activity. October management estimates indicate further growth in billable minutes, subject to reconciliation and revenue recognition.

• Operations are scaling through higher Care Coordinator capacity and a new Treasure Coast Community Health agreement; cash-flow breakeven remains a conditional H1 2027 target.

Financial highlights

• September-quarter fee-for-service revenue was US$695,911, up 24% QoQ from ~US$561,000; total operating revenue was ~US$960,504, up 29% from ~US$745,000.

• Revenue mix: FFS ~US$696,000, UPEC US$174,000 and other revenue US$91,000; FFS generated the largest incremental increase.

• Customer cash receipts were A$1.015m, up 9% QoQ; collections lagged activity amid claims processing and billing reconciliation.

• Net operating cash outflow was A$2.081m versus ~A$1.69m in the prior quarter; quarter-end cash was A$862,000.

Outlook and guidance

• October billable care minutes were estimated at ~263,000, up 50% from September actuals; October revenue was estimated at US$450,000, subject to reconciliation and revenue recognition.

• October revenue implies an illustrative annualised run-rate of US$5.4m/~A$8.1m, nearly 90% above FY2026 audited revenue of A$4.29m; this is not a forecast.

• Cash-flow breakeven remains targeted for H1 2027; pro forma operating profitability is expected earlier, subject to enrolments, billing, collections, cost discipline and funding.

• Workforce targets are 48 Care Coordinators by November and ~115 during Q1 2027, aligned with anticipated patient demand.